Chronic exposure to the opioid antagonist naltrexone during pregnancy: Maternal and offspring effects

Physiology and Behavior

Volumn 62, Issue 3, 1997, Pages 501-508

  McLaughlin, Patricia J ^a   Tobias, Steven W ^a   Lang, C Max ^a   Zagon, Ian S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Development; Growth factors; Maternal; Naltrexone; Opioid antagonist; Opioids; Organ growth; Postnatal; Prenatal

Indexed keywords

ENDORPHIN; NALTREXONE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN; CHILDBIRTH; CONTROLLED STUDY; CROWN RUMP LENGTH; FEMALE; HEART; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LITTER SIZE; LIVER; LONG TERM EXPOSURE; MALE; MOTHER; NEWBORN; NONHUMAN; ONTOGENY; ORGAN WEIGHT; PERINATAL PERIOD; PREGNANCY; PRENATAL DRUG EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; RAT; SKELETAL MUSCLE; TRICEPS SURAE MUSCLE;

EID: 0030882968     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00007-3     Document Type: Article

References (36)

1. Akil H, Watson S. J., Young E., Lewis M. E., Katchaturian H., Walter J. M. Endogenous opioids: Biology and function. Annu. Rev. Neurosci. 7:1984;223-255.
2. Barg J., Belcheva M., McHale R., Levey R., Vogel Z., Coscia C. J. β -endorphin is a potent inhibitor of thymidine incorporation into DNA via μ - and κ -opioid receptors in fetal rat brain cell aggregates in culture. J. Neurochem. 60:1993;765-767.
3. Bartolome J. V., Bartolome M. B., Lorber B. A., Dileo S. J., Schanberg S. M. Effects of central administration of beta-endorphin on brain and liver DNA-synthesis in preweaning rats. Neuroscience. 40:1991;289-294.
4. Cohen E., Keshet G., Shavit Y., Weinstock M. Prenatal naltrexone facilitates male sexual behavior in the rat. Pharmacol. Biochem. Behav. 54:1996;183-189.
5. D'Amato F. R., Castellano C., Ammassari-Teule M., Oliverio A. Prenatal antagonism of stress by naltrexone administration: Early and long-lasting effects on emotional behaviors in mice. Develop. Psychobiol. 21:1988;283-292.
6. Diggle P. J., Liang K. Y., Zeger S. L. Analysis of Longitudinal Data. 1994;Clarendon Press, Oxford.
7. Harry G. J., Rosecrans J. A. Behavioral effects of perinatal naltrexone exposure: A preliminary investigation. Pharmacol. Biochem. Behav. 11:((Suppl.)):1979;19-22.
8. Hauser K. F., McLaughlin P. J., Zagon I. S. Endogenous opioid systems and the regulation of dendritic growth and spine formation. J. Comp. Neurol. 281:1989;13-22.
9. Hetta J., Terenius L. Prenatal naloxone affects survival and morphine sensitivity of rat offspring. Neurosci. Letts. 16:1980;323-327.
10. Keshet G. I., Weinstock M. Maternal naltrexone prevents morphological and behavioral alterations induced in rats by prenatal stress. Pharmacol. Biochem. Behav. 50:1995;413-419.
11. Leng G., Mansfield S., Bicknell R. J., Dean A. D. P., Ingram C. D., Marsh M. I. C., Yates J. O., Dyer R. G. Central opioids: A possible role in parturition? J. Endocrinol. 106:1985;219-224.
12. Mayer A. D., Faris P. L., Komisaruk B. R., Rosenblatt J. S. Opiate antagonism reduces placentophagia and pup cleaning by parturient rats. Pharmacol. Biochem. Behav. 22:1985;1035-1044.
13. McLaughlin P. J. Opioid antagonist modulation of rat heart development. Life Sci. 54:1994;1423-1431.
14. 5]-enkephalin. Am. J. Physiol. 271:1996;R122-R129.
15. Meriney S. D., Ford M. J., Oliva D., Pilar G. Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion. J. Neurosci. 11:1991;3705-3717.
16. Monder H., Yasukawa N., Christian J. J. Perinatal naloxone: When does naloxone affect hyperalgesia? Pharmacol. Biochem. Behav. 11:1979;235-237.
17. Murgo, A. J. Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J. Natl. Cancer Inst. 75341-75344; 1985.
18. Nieder G. L., Corder C. N. Effects of opiate antagonists on early pregnancy and pseudopregnancy in mice. J. Reprod. Fert. 65:1982;341-346.
19. Pfeiffer D. G., Nikolarakis K. E., Pfeiffer A. Chronic blockade of opiate receptors: Influence on reproduction and body weight in female rats. Neuropeptides. 5:1984;279-282.
20. Seatriz J. V., Hammer R. P. Effects of opiates on neuronal development in the rat cerebral cortex. Brain Res. Bull. 30:1993;523-527.
21. + murine T cells. J. Pharmacol. Exp. Ther. 273:1995;1105-1113.
22. Shepanek N. A., Smith R. F., Anderson L. A., Medici C. N. Behavioral and developmental changes associated with prenatal opiate receptor blockade. Pharmacol. Biochem. Behav. 50:1995;313-319.
23. Shepanek N. A., Smith R. F., Tyer Z., Royall D., Allen K. Developmental, behavioral, and structural effects of prenatal opiate receptor blockade. New York Acad. Sci. 562:1989;377-379.
24. Villiger P. M., Lotz M. Expression of prepro-enkephalin in human articular chondrocytes is linked to cell proliferation. EMBO J. 11:1992;135-143.
25. Vorhees C. V. Effects of prenatal naloxone exposure on postnatal behavioral development of rats. Neurobehav. Toxicol. Teratol. 3:1981;295-301.
26. Ward O. B., Monaghan E. P., Ward I. L. Naltrexone blocks the effects of prenatal stress on sexual behavior differentiation in male rats. Pharmacol. Biochem. Behav. 25:1986;573-576.
27. Zagon I. S., Hytrek S. D., McLaughlin P. J. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am. J. Physiol. 271:1996;R511-R518.
28. Zagon I. S., McLaughlin P. J. Increased brain size and cellular content in infant rats treated with opiate antagonist. Science. 221:1983;1179-1180.
29. Zagon I. S., McLaughlin P. J. Naltrexone modulates growth in infant rats. Life Sci. 33:1983;2449-2454.
30. Zagon I. S., McLaughlin P. J. Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth. Life Sci. 35:1984;2057-2064.
31. Zagon I. S., McLaughlin P. J. Opioid antagonist-induced regulation of organ development. Physiol. Behav. 34:1985;507-511.
32. Zagon I. S., McLaughlin P. J. Naloxone modulates body and organ growth of rats: Dependency on the duration of opioid receptor blockade and stereospecificity. Pharmacol. Biochem. Behav. 33:1989;325-328.
33. Zagon I. S., McLaughlin P. J. The role of endogenous opioids and opioid receptors in human and animal cancers. Plotnikoff N. P., Murgo A. J., Faith R. E., Wybran J. Stress and Immunity. 1991;343-356 CRC, Caldwell, NJ.
34. Zagon I. S., McLaughlin P. J. Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res. 542:1991;318-323.
35. Zagon I. S., McLaughlin P. J. Opioid growth factor receptor in the developing nervous system. Zagon I. S., McLaughlin P. J. Receptors in the Developing Nervous System. Growth Factors and Hormones. 1:199;39-62 Chapman and Hall, London.
36. Zagon I. S., Sassani J. W., McLaughlin P. J. Opioid growth factor modulates corneal epithelial outgrowth in tissue culture. Am. J. Physiol. 268:1995;R942-R950.